Suping Li
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Advanced biosensing and bioanalysis techniques 21
- RNA Interference and Gene Delivery 13
- Extracellular vesicles in disease 10
- Oncology 29
- Inflammatory Biomarkers in Disease Prognosis 8
- Cancer Immunotherapy and Biomarkers 6
- Co-authors
- Guangjun Nie (41 shared papers)Gregory J. Anderson (9 shared papers)Yanhua Tian (3 shared papers)Tianjiao Ji (7 shared papers)Jingyan Wei (10 shared papers)Jian Song (1 shared paper)Motao Zhu (1 shared paper)Yinlong Zhang (16 shared papers)
- Journals
- Cancer Research (4 papers)Chinese Chemical Letters (3 papers)Nano Today (3 papers)The Analyst (3 papers)Nature Communications (3 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Suping Li
152 papers receiving 6.8k citations
Suping Li's Hit Papers
Peers
Comparison fields: 5 of 159
- Cancer Research 1.2k
- Biomaterials 1.0k
- Molecular Biology 3.7k
- Biomedical Engineering 2.0k
- Electrochemistry 197
Countries citing papers authored by Suping Li
This map shows the geographic impact of Suping Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suping Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suping Li more than expected).
Fields of papers citing papers by Suping Li
This network shows the impact of papers produced by Suping Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suping Li. The network helps show where Suping Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Suping Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 163 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy Hit paper breakdown → | 2013 | 1563 |
| 2 | A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo Hit paper breakdown → | 2018 | 1252 |
| 3 | 2016 | 304 | |
| 4 | 2019 | 200 | |
| 5 | 2019 | 173 | |
| 6 | 2017 | 156 | |
| 7 | 2021 | 133 | |
| 8 | 2016 | 131 | |
| 9 | 2020 | 129 | |
| 10 | 2016 | 127 | |
| 11 | The dynamic role of platelets in cancer progression and their therapeutic implications Hit paper breakdown → | 2023 | 105 |
| 12 | 2013 | 84 | |
| 13 | 2020 | 84 | |
| 14 | 2017 | 81 | |
| 15 | 2018 | 75 | |
| 16 | 2018 | 70 | |
| 17 | 2016 | 65 | |
| 18 | 2014 | 63 | |
| 19 | 2019 | 56 | |
| 20 | 2018 | 55 |
About Suping Li
Suping Li is a scholar working on Molecular Biology, Oncology, Biomedical Engineering, Cancer Research and Pulmonary and Respiratory Medicine, having authored 163 papers that have together received 6.9k indexed citations. Recurring topics across this work include Advanced biosensing and bioanalysis techniques (21 papers), Nanoplatforms for cancer theranostics (15 papers), RNA Interference and Gene Delivery (13 papers), Nanoparticle-Based Drug Delivery (10 papers), Extracellular vesicles in disease (10 papers), Platelet Disorders and Treatments (9 papers), Inflammatory Biomarkers in Disease Prognosis (8 papers) and Cancer Immunotherapy and Biomarkers (6 papers). The work is most often cited by research in Cancer Research (1.2k citations), Biomaterials (1.0k citations), Molecular Biology (3.7k citations), Biomedical Engineering (2.0k citations) and Electrochemistry (197 citations). Suping Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Guangjun Nie, Gregory J. Anderson, Yanhua Tian, Tianjiao Ji, Jingyan Wei, Jian Song, Motao Zhu, Yinlong Zhang, Guobao Xu and Jianping Lai. Their work appears in journals such as Cancer Research, Chinese Chemical Letters, Nano Today, The Analyst and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.